AMERICAN BRIVISION (HOLDING) CORPORATION (OTCMKTS:MTOO) Files An 8-K Other Events

AMERICAN BRIVISION (HOLDING) CORPORATION (OTCMKTS:MTOO) Files An 8-K Other Events
Item 8.01. Other Events

On November 22, 2016, American BriVision (Holding) Corporation (the “Company”) was informed by its independent registered accountants, Centurion ZD CPA Limited, or formerly known as DCAW (CPA) Limited (“DCAW”) that the firm has changed the name to “Centurion ZD CPA Limited”, effective November 22, 2016. The office addresses and telephone numbers of the firm remain unchanged.

 


About AMERICAN BRIVISION (HOLDING) CORPORATION (OTCMKTS:MTOO)

American BriVision (Holding) Corporation, formerly Metu Brands, Inc., is a holding company operating through its subsidiary, American BriVision Corporation. The Company is a biotechnology company focused on the development of drugs and medical devices. The Company is a clinical-stage biopharmaceutical company focused on utilizing its licensed technology to enhance the development of pre-existing pharmaceutical products for the treatment of various cancer indications and other diseases; prospectively identify patients that may respond to such pharmaceutical products, and commercialize such pharmaceutical products for license in various markets. The Company’s operation is the research and development of five compound licensed to the Company by BioLite Inc. The compounds include ABV- 1501, ABV-1502, ABV-1503, ABV-1504 and ABV-1505. The Company has no revenue generated from its principal operations in clinical product development through research and development activities.

AMERICAN BRIVISION (HOLDING) CORPORATION (OTCMKTS:MTOO) Recent Trading Information

AMERICAN BRIVISION (HOLDING) CORPORATION (OTCMKTS:MTOO) closed its last trading session at 25.00 with shares trading hands.

An ad to help with our costs